latest research favipiravir Helping patients infected with covid, less symptoms, 79% better.
The results showed that Patients in the program started on average at 1.7 days after symptom onset when assessed by NEWS over a 14-day treatment period. The favipiravir treatment group improved by 79%, compared to 32.3% in the control group. The favipiravir group improved significantly faster. by half Patients who received favipiravir showed improvement from … Read more